474 related articles for article (PubMed ID: 17927473)
1. Carbapenemases: molecular diversity and clinical consequences.
Poirel L; Pitout JD; Nordmann P
Future Microbiol; 2007 Oct; 2(5):501-12. PubMed ID: 17927473
[TBL] [Abstract][Full Text] [Related]
2. Emerging carbapenemases in Gram-negative aerobes.
Nordmann P; Poirel L
Clin Microbiol Infect; 2002 Jun; 8(6):321-31. PubMed ID: 12084099
[TBL] [Abstract][Full Text] [Related]
3. [Gram-negative bacteriae with resistance to carbapenems].
Nordmann P
Med Sci (Paris); 2010 Nov; 26(11):950-9. PubMed ID: 21106177
[TBL] [Abstract][Full Text] [Related]
4. Carbapenemases in Enterobacteriaceae: types and molecular epidemiology.
Martínez-Martínez L; González-López JJ
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():4-9. PubMed ID: 25542046
[TBL] [Abstract][Full Text] [Related]
5. Class A carbapenemases.
Walther-Rasmussen J; Høiby N
J Antimicrob Chemother; 2007 Sep; 60(3):470-82. PubMed ID: 17595289
[TBL] [Abstract][Full Text] [Related]
6. Carbapenemases: the versatile beta-lactamases.
Queenan AM; Bush K
Clin Microbiol Rev; 2007 Jul; 20(3):440-58, table of contents. PubMed ID: 17630334
[TBL] [Abstract][Full Text] [Related]
7. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens.
Pfeifer Y; Cullik A; Witte W
Int J Med Microbiol; 2010 Aug; 300(6):371-9. PubMed ID: 20537585
[TBL] [Abstract][Full Text] [Related]
8. Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP).
Mataseje LF; Bryce E; Roscoe D; Boyd DA; Embree J; Gravel D; Katz K; Kibsey P; Kuhn M; Mounchili A; Simor A; Taylor G; Thomas E; Turgeon N; Mulvey MR;
J Antimicrob Chemother; 2012 Jun; 67(6):1359-67. PubMed ID: 22398651
[TBL] [Abstract][Full Text] [Related]
9. Current status of carbapenemases in Latin America.
Maya JJ; Ruiz SJ; Blanco VM; Gotuzzo E; Guzman-Blanco M; Labarca J; Salles M; Quinn JP; Villegas MV
Expert Rev Anti Infect Ther; 2013 Jul; 11(7):657-67. PubMed ID: 23879607
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of decreased susceptibility to carbapenems among Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii and investigation of carbapenemases.
Lee HK; Park YJ; Kim JY; Chang E; Cho SG; Chae HS; Kang CS
Diagn Microbiol Infect Dis; 2005 Aug; 52(4):331-6. PubMed ID: 15994052
[TBL] [Abstract][Full Text] [Related]
11. Characterization of carbapenemases, extended spectrum β-lactamases and molecular epidemiology of carbapenem-non-susceptible Enterobacter cloacae in a Chinese hospital in Chongqing.
Dai W; Sun S; Yang P; Huang S; Zhang X; Zhang L
Infect Genet Evol; 2013 Mar; 14():1-7. PubMed ID: 23220359
[TBL] [Abstract][Full Text] [Related]
12. A convenient microbiological assay employing cell-free extracts for the rapid characterization of Gram-negative carbapenemase producers.
Marchiaro P; Ballerini V; Spalding T; Cera G; Mussi MA; Morán-Barrio J; Vila AJ; Viale AM; Limansky AS
J Antimicrob Chemother; 2008 Aug; 62(2):336-44. PubMed ID: 18456651
[TBL] [Abstract][Full Text] [Related]
13. [Beta-lactamases and their role in resistance. PART 2: beta-lactamases in 21st century].
Bedenić B
Lijec Vjesn; 2005; 127(1-2):12-21. PubMed ID: 16145868
[TBL] [Abstract][Full Text] [Related]
14. Clinically significant carbapenemases: an update.
Walsh TR
Curr Opin Infect Dis; 2008 Aug; 21(4):367-71. PubMed ID: 18594288
[TBL] [Abstract][Full Text] [Related]
15. [Carbapenemases in enterobacteriaceae].
Nordmann P; Carrer A
Arch Pediatr; 2010 Sep; 17 Suppl 4():S154-62. PubMed ID: 20826325
[TBL] [Abstract][Full Text] [Related]
16. [MULTIRESISTANT BACTERIA].
Bedenić B; Sardelić S; Ladavac M
Acta Med Croatica; 2015 Sep; 69(3):211-6. PubMed ID: 29077379
[TBL] [Abstract][Full Text] [Related]
17. [Carbapenemases of gram-negative bacteria].
Bedenić B; Sardelić S; Vranić-Ladavac M; Barisić N; Ladavac R
Lijec Vjesn; 2014; 136(3-4):94-103. PubMed ID: 24988745
[TBL] [Abstract][Full Text] [Related]
18. [Beta-lactamases of Gram negative bacteria: never-ending clockwork!].
Philippon A; Arlet G
Ann Biol Clin (Paris); 2006; 64(1):37-51. PubMed ID: 16420989
[TBL] [Abstract][Full Text] [Related]
19. [Development of Beta-lactamase resistance in enterobacteria].
Koren J; Vaculíková A
Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):103-7. PubMed ID: 17051471
[TBL] [Abstract][Full Text] [Related]
20. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004).
Deshpande LM; Jones RN; Fritsche TR; Sader HS
Microb Drug Resist; 2006; 12(4):223-30. PubMed ID: 17227206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
